Molecular signatures of high salt induced pathogenic T cells

高盐诱导致病性 T 细胞的分子特征

基本信息

  • 批准号:
    8679551
  • 负责人:
  • 金额:
    $ 11.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our objective is to define molecular signals that lead to activation of the mucosal immune system leading to autoimmune intestinal inflammation. We believe that these signals will lead to identification of therapeutic targets and help understand the pathogenesis of several human diseases including Inflammatory Bowel Disease (IBD). Th17 cells are highly proinflammatory cells that are critical for different autoimmune diseases. We have developed a research program that is aimed to elucidate the balance between inflammatory Th17 cells and the anti-inflammatory, regulatory T cells, Tregs. Our observation is that the balance between Th17 and Tregs is essential for tissue homeostasis in the gut. Thus, to identify novel regulators with Th17 cells, we performed temporal gene expression profiling of Th17 cells during differentiation. We found a target - SGK1, a kinase that is highly expressed in both Th17 and Tregs and regulates sodium intake of a cell. We discovered that SGK1 is critical stabilizing the Th17 cell phenotype. We also showed that a modest increase in salt concentration induces SGK1 expression and enhances Th17 cell. The goal of this proposal is to understand that the chronic high salt intake in western diets, on a genetically susceptible background, may act as a trigger for developing IBD by inducing pathogenic Th17 cells and disarming protective Tregs via SGK1. Furthermore, such study will ultimately facilitate the identification of environment triggers for the development of pathogenic Th17 cells and autoimmune diseases. We will then 1) investigate whether SGK1 regulates the reciprocal differentiation of Foxp3+ Treg and Th17 cell; 2) test that high salt intake can influenc the IBD development via induction of pathogenic Th17 and disarming Tregs mediated by SGK1; 3) computationally reconstruct an unbiased, mechanistic network within T cells of the interactions between proteins and genes that mediate the effect of high salt. This will allow us to identify potential key regulators and drug targets that may overlap with IBD-susceptibility genes, and to examine with targeted perturbation their roles in influencing Th17/Treg balance and development of IBD. We can then explore the potential therapeutic approaches for IBD and other autoimmune diseases. My short-term goal is to learn more about IBD research and understand the underlying T cell intrinsic and environmental cues that induce autoimmune T cells are induced to mediate gut autoimmunity. My long-term goal is to develop into an independent investigator in an academic setting. My research program will focus on the identification of new factors which can regulate T cell subsets differentiation and triggers for T cell- mediated autoimmune disorders, with the ultimate goal of identifying novel targets for therapeutic interventions for these diseases.
描述(由申请人提供):我们的目的是确定导致粘膜免疫系统激活的分子信号,从而导致自身免疫性肠道炎症。我们相信,这些信号将导致治疗靶点的识别,并有助于了解包括炎症性肠病(IBD)在内的几种人类疾病的发病机制。Th 17细胞是高度促炎细胞,对不同的自身免疫性疾病至关重要。我们已经开发了一个研究计划,旨在阐明炎症性Th 17细胞和抗炎性调节性T细胞之间的平衡。我们的观察结果是,Th 17和Tcl 4之间的平衡对于肠道中的组织稳态是必不可少的。因此,为了鉴定Th 17细胞的新调节剂,我们在分化期间对Th 17细胞进行了时间基因表达谱分析。我们发现了一个靶点-SGK 1,这是一种在Th 17和Tcl 2中高度表达的激酶,可调节细胞的钠摄入量。我们发现SGK 1对稳定Th 17细胞表型至关重要。我们还表明,盐浓度的适度增加诱导SGK 1表达并增强Th 17细胞。 这项建议的目的是了解西方饮食中的慢性高盐摄入, 遗传易感背景,可能通过诱导致病性Th 17细胞和通过SGK 1解除保护性T细胞而触发IBD的发展。此外,这样的研究将最终有助于识别致病性Th 17细胞和自身免疫性疾病发展的环境触发因素。然后我们将1)研究SGK 1是否调节Foxp 3 + Treg和Th 17细胞的相互分化; 2)测试高盐摄入可以通过诱导致病性Th 17和解除SGK 1介导的Treg来影响IBD的发展; 3)计算重建介导高盐效应的蛋白质和基因之间相互作用的T细胞内无偏的机制网络。这将使我们能够 确定可能与IBD易感基因重叠的潜在关键调节因子和药物靶点,并通过靶向干扰来检查它们在影响Th 17/Treg平衡和IBD发展中的作用。然后,我们可以探索IBD和其他自身免疫性疾病的潜在治疗方法。 我的短期目标是更多地了解IBD研究,并了解诱导自身免疫性T细胞介导肠道自身免疫的潜在T细胞内在和环境线索。我的长期目标是发展成为一名独立的学术研究者。我的研究计划将集中在识别可以调节T细胞亚群分化和触发T细胞介导的自身免疫性疾病的新因子,最终目标是为这些疾病的治疗干预确定新的靶点。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ezh2 lines up the chromatin in T regulatory cells.
  • DOI:
    10.1016/j.immuni.2015.01.019
  • 发表时间:
    2015-02-17
  • 期刊:
  • 影响因子:
    32.4
  • 作者:
    Wu C;Chen Z;Kuchroo VK
  • 通讯作者:
    Kuchroo VK
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chuan Wu其他文献

Chuan Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chuan Wu', 18)}}的其他基金

Molecular signatures of high salt induced pathogenic T cells
高盐诱导致病性 T 细胞的分子特征
  • 批准号:
    9131613
  • 财政年份:
    2015
  • 资助金额:
    $ 11.14万
  • 项目类别:
CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity
CD101 控制上皮内细胞 (IEL) 维持肠道屏障完整性
  • 批准号:
    10702680
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
The role of Foxo1 for intestinal epithelial cells during mucosal immune response
Foxo1在粘膜免疫反应中对肠上皮细胞的作用
  • 批准号:
    10702653
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
IL-33 promotes serotonin release from enterochromaffin cells
IL-33 促进肠嗜铬细胞释放血清素
  • 批准号:
    10487139
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
The role of Foxo1 for intestinal epithelial cells during mucosal immune response
Foxo1在粘膜免疫反应中对肠上皮细胞的作用
  • 批准号:
    10486952
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
IL-33 promotes serotonin release from enterochromaffin cells
IL-33 促进肠嗜铬细胞释放血清素
  • 批准号:
    10702826
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
Inter- and intra-epithelial regulation for intestinal barrier integrity
肠屏障完整性的上皮间和上皮内调节
  • 批准号:
    10926306
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity
CD101 控制上皮内细胞 (IEL) 维持肠道屏障完整性
  • 批准号:
    10486983
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
T cell regulation for intestinal barrier function
T 细胞对肠道屏障功能的调节
  • 批准号:
    10926331
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:
Immune-neuron crosstalk regulates intestinal homeostasis
免疫神经元串扰调节肠道稳态
  • 批准号:
    10926462
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了